Accéder au contenu
Merck

[An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].

Masui. The Japanese journal of anesthesiology (2006-07-22)
Hiroshi Iwasaki
RÉSUMÉ

For many years, much effort has been done to develop non-depolarizing neuromuscular blocking agents of rapid onset and short duration. It has been shown that rocuronium bromide is a nondepolarizing, steroidal muscle relaxant with fast onset and short-to-intermediate duration of action. In addition, rocuronium-induced neuromuscular blockade can be readily and consistently reversed following the administration of reversal agents. The pharmacology and pharmacodynamics of rocuronium bromide are summarized in this review.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Rocuronium bromide, ≥97% (perchloric acid titration)
Rocuronium for peak identification, European Pharmacopoeia (EP) Reference Standard
Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard